Instil Bio, Inc.
TIL
$16.00
$0.5453.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.90M | -23.02M | -14.92M | -24.30M | -12.93M |
| Total Depreciation and Amortization | 741.00K | 901.00K | 975.00K | 993.00K | 1.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.67M | 11.32M | 4.35M | 7.10M | -441.00K |
| Change in Net Operating Assets | -4.07M | -9.33M | -1.02M | 1.82M | -1.05M |
| Cash from Operations | -10.56M | -20.13M | -10.61M | -14.39M | -13.38M |
| Capital Expenditure | -- | -- | -- | -- | -58.00K |
| Sale of Property, Plant, and Equipment | 320.00K | 5.00K | 541.00K | -- | 1.56M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.68M | 19.81M | 11.38M | 9.24M | 12.45M |
| Cash from Investing | 13.00M | 19.81M | 11.92M | 9.24M | 13.95M |
| Total Debt Issued | 85.60M | -- | -- | -- | 0.00 |
| Total Debt Repaid | -82.84M | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 206.00K | 159.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.37M | -- | -- | -- | -- |
| Cash from Financing | 1.60M | 159.00K | -- | -- | 0.00 |
| Foreign Exchange rate Adjustments | -65.00K | 42.00K | -8.00K | -63.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.97M | -118.00K | 1.30M | -5.21M | 550.00K |